Drug Type Small molecule drug |
Synonyms Montelukast/mometasone |
Target |
Action antagonists, agonists |
Mechanism CysLT1 antagonists(Cysteinyl leukotriene receptor 1 antagonists), GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H30Cl2O6 |
InChIKeyWOFMFGQZHJDGCX-ZULDAHANSA-N |
CAS Registry83919-23-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Phase 2 | United Kingdom | - | |
| Asthma | Phase 2 | South America | - | |
| Asthma | Phase 2 | Israel | - | |
| Asthma | Phase 2 | North America | - |





